MHU-650

N/A

Report date: 2022/01/19 16:51:00

Base Information

Drug NameMHU-650
Drug Alias NameMHU-650
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Edema +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Edema +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A